Style de citation APA (7e éd.)

Tian, T., Hong, F., Wang, Z., Hu, J., Chen, N., Lv, L., & Yi, Q. (2021). HSD17B6 downregulation predicts poor prognosis and drives tumor progression via activating Akt signaling pathway in lung adenocarcinoma. Nature Publishing Group.

Style de citation Chicago (17e éd.)

Tian, Tian, Fu Hong, Zhiwen Wang, Jiaru Hu, Ni Chen, Lei Lv, et Qiyi Yi. HSD17B6 Downregulation Predicts Poor Prognosis and Drives Tumor Progression via Activating Akt Signaling Pathway in Lung Adenocarcinoma. Nature Publishing Group, 2021.

Style de citation MLA (8e éd.)

Tian, Tian, et al. HSD17B6 Downregulation Predicts Poor Prognosis and Drives Tumor Progression via Activating Akt Signaling Pathway in Lung Adenocarcinoma. Nature Publishing Group, 2021.